Ubiquitin-proteasome degradation of KLF5 transcription factor in cancer and untransformed epithelial cells

被引:117
作者
Chen, CS
Sun, XD
Ran, QM
Wilkinson, KD
Murphy, TJ
Simons, JW
Dong, JT
机构
[1] Emory Univ, Sch Med, Winship Canc Ctr, Dept Oncol & Hematol, Atlanta, GA 30322 USA
[2] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA
[3] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA
[4] Emory Univ, Sch Med, Dept Urol, Atlanta, GA 30322 USA
[5] Emory Univ, Sch Med, Program Genet & Mol Biol, Atlanta, GA 30322 USA
关键词
KLF5; degradation; ubiquitin; proteasome; cancer;
D O I
10.1038/sj.onc.1208497
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Ubiquitin-mediated proteolysis plays a central role in controlling intracellular levels of essential regulatory molecules such as p53, cyclins, myc, BRCA1, HIF-1 alpha, etc. The Kruppel-like factor 5 (KLF5) transcription factor regulates biological processes involved in carcinogenesis, angiogenesis, and smooth muscle cell differentiation. In carcinogenesis, KLF5's role has been indicated by frequent genetic deletion as well as functional studies. Here we show that KLF5 is an unstable protein with a short half-life. Destruction of KLF5 was prevented by each of the proteasome-specific inhibitors tested but not by an inhibitor for trypsin-like proteases and cysteine proteases or by a lysosome inhibitor in epithelial cells. Furthermore, KLF5 underwent ubiquitination, and deletion of a 56-amino-acid sequence adjacent to a known transactivation domain of KLF5 significantly reduced its ubiquitination and degradation. Interestingly, cancer cells appeared to be more active in KLF5 degradation than untransformed epithelial cells, yet their proteasome activity was not higher. These results suggest that KLF5 protein is degraded at least in part through ubiquitination-proteasome pathway, which may have become hyperactive for KLF5 in cancer cells.
引用
收藏
页码:3319 / 3327
页数:9
相关论文
共 40 条
  • [1] Positive- and negative-acting Kruppel-like transcription factors bind a transforming growth factor β control element required for expression of the smooth muscle cell differentiation marker SM22α in vivo
    Adam, PJ
    Regan, CP
    Hautmann, MB
    Owens, GK
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (48) : 37798 - 37806
  • [2] Regulation of platelet-derived growth factor-A chain by Kruppel-like factor 5 -: New pathway of cooperative activation with nuclear factor-κB
    Aizawa, K
    Suzuki, T
    Kada, N
    Ishihara, A
    Kawai-Kowase, K
    Matsumura, T
    Sasaki, K
    Munemasa, Y
    Manabe, I
    Kurabayashi, M
    Collins, T
    Nagai, R
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (01) : 70 - 76
  • [3] Intestinal tumor progression is associated with altered function of KLF5
    Bateman, NW
    Tan, DF
    Pestell, RG
    Black, JD
    Black, AR
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (13) : 12093 - 12101
  • [4] Sp1 and kruppel-like factor family of transcription factors in cell growth regulation and cancer
    Black, AR
    Black, JD
    Azizkhan-Clifford, J
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 2001, 188 (02) : 143 - 160
  • [5] Reduced MAP kinase phosphatase-1 degradation after p42/p44MAPK-dependent phosphorylation
    Brondello, JM
    Pouysségur, J
    McKenzie, FR
    [J]. SCIENCE, 1999, 286 (5449) : 2514 - 2517
  • [6] Regulation of E2F through ubiquitin-proteasome-dependent degradation: Stabilization by the pRB tumor suppressor protein
    Campanero, MR
    Flemington, EK
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (06) : 2221 - 2226
  • [7] A possible tumor suppressor role of the KLF5 transcription factor in human breast cancer
    Chen, C
    Bhalala, HV
    Qiao, H
    Dong, JT
    [J]. ONCOGENE, 2002, 21 (43) : 6567 - 6572
  • [8] KLF5 is frequently deleted and down-regulated but rarely mutated in prostate cancer
    Chen, C
    Bhalala, HV
    Vessella, RL
    Dong, JT
    [J]. PROSTATE, 2003, 55 (02) : 81 - 88
  • [9] Regulation of KLF5 involves the Sp1 transcription factor in human epithelial cells
    Chen, CS
    Zhou, YF
    Zhou, ZM
    Sun, XD
    Otto, KB
    Uht, RM
    Dong, JT
    [J]. GENE, 2004, 330 : 133 - 142
  • [10] SIGNAL-INDUCED SITE-SPECIFIC PHOSPHORYLATION TARGETS I-KAPPA-B-ALPHA TO THE UBIQUITIN-PROTEASOME PATHWAY
    CHEN, ZJ
    HAGLER, J
    PALOMBELLA, VJ
    MELANDRI, F
    SCHERER, D
    BALLARD, D
    MANIATIS, T
    [J]. GENES & DEVELOPMENT, 1995, 9 (13) : 1586 - 1597